GYLDEN PHARMA LIMITED
Overview
Company Name | GYLDEN PHARMA LIMITED |
---|---|
Company Status | Active |
Legal Form | Private limited company |
Company Number | 09955881 |
Jurisdiction | England/Wales |
Date of Creation |
Summary
Has Super Secure PSCs | No |
---|---|
Has Charges | No |
Has Insolvency History | No |
Registered Office is in Dispute | No |
What is the purpose of GYLDEN PHARMA LIMITED?
- Research and experimental development on biotechnology (72110) / Professional, scientific and technical activities
Where is GYLDEN PHARMA LIMITED located?
Registered Office Address | 4 & 5 Dunmore Court Wootton Road OX13 6BH Abingdon Oxfordshire England |
---|---|
Undeliverable Registered Office Address | No |
What were the previous names of GYLDEN PHARMA LIMITED?
Company Name | From | Until |
---|---|---|
EMERGEX VACCINES HOLDING LIMITED | Jan 18, 2016 | Jan 18, 2016 |
What are the latest accounts for GYLDEN PHARMA LIMITED?
Overdue | Yes |
---|---|
Next Accounts | |
Next Accounts Period End On | Mar 31, 2024 |
Next Accounts Due On | Mar 31, 2025 |
Last Accounts | |
Last Accounts Made Up To | Mar 31, 2023 |
What is the status of the latest confirmation statement for GYLDEN PHARMA LIMITED?
Last Confirmation Statement Made Up To | Aug 07, 2025 |
---|---|
Next Confirmation Statement Due | Aug 21, 2025 |
Last Confirmation Statement | |
Next Confirmation Statement Made Up To | Aug 07, 2024 |
Overdue | No |
What are the latest filings for GYLDEN PHARMA LIMITED?
Date | Description | Document | Type | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Resolutions Resolutions | 2 pages | RESOLUTIONS | ||||||||||||||||||||||
| ||||||||||||||||||||||||
Memorandum and Articles of Association | 58 pages | MA | ||||||||||||||||||||||
Memorandum and Articles of Association | 58 pages | MA | ||||||||||||||||||||||
Memorandum and Articles of Association | 58 pages | MA | ||||||||||||||||||||||
Statement of capital following an allotment of shares on Dec 18, 2024
| 4 pages | SH01 | ||||||||||||||||||||||
Resolutions Resolutions | 1 pages | RESOLUTIONS | ||||||||||||||||||||||
| ||||||||||||||||||||||||
Statement of capital following an allotment of shares on Dec 12, 2024
| 4 pages | SH01 | ||||||||||||||||||||||
Memorandum and Articles of Association | 58 pages | MA | ||||||||||||||||||||||
Resolutions Resolutions | 1 pages | RESOLUTIONS | ||||||||||||||||||||||
| ||||||||||||||||||||||||
Certificate of change of name Company name changed emergex vaccines holding LIMITED\certificate issued on 16/10/24 | 3 pages | CERTNM | ||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
Statement of capital following an allotment of shares on Oct 03, 2024
| 4 pages | SH01 | ||||||||||||||||||||||
Termination of appointment of Michael Derek Vaughn Rake as a director on Sep 03, 2024 | 1 pages | TM01 | ||||||||||||||||||||||
Confirmation statement made on Aug 07, 2024 with updates | 16 pages | CS01 | ||||||||||||||||||||||
Director's details changed for Mr Sergio Pagani on Jul 12, 2024 | 2 pages | CH01 | ||||||||||||||||||||||
Statement of capital following an allotment of shares on Mar 28, 2024
| 4 pages | SH01 | ||||||||||||||||||||||
Appointment of Dr Poh Hui Chia as a director on Jan 05, 2024 | 2 pages | AP01 | ||||||||||||||||||||||
Termination of appointment of Xinhong Lim as a director on Jan 05, 2024 | 1 pages | TM01 | ||||||||||||||||||||||
Statement of capital following an allotment of shares on Nov 20, 2023
| 4 pages | SH01 | ||||||||||||||||||||||
Appointment of Dr Ricardo De Godoi Mattos Ferreira as a director on Sep 27, 2023 | 2 pages | AP01 | ||||||||||||||||||||||
Group of companies' accounts made up to Mar 31, 2023 | 17 pages | AA | ||||||||||||||||||||||
Statement of capital following an allotment of shares on Sep 27, 2023
| 4 pages | SH01 | ||||||||||||||||||||||
Statement of capital following an allotment of shares on Aug 21, 2023
| 4 pages | SH01 | ||||||||||||||||||||||
Resolutions Resolutions | 2 pages | RESOLUTIONS | ||||||||||||||||||||||
| ||||||||||||||||||||||||
Memorandum and Articles of Association | 57 pages | MA | ||||||||||||||||||||||
Confirmation statement made on Aug 07, 2023 with updates | 15 pages | CS01 | ||||||||||||||||||||||
Who are the officers of GYLDEN PHARMA LIMITED?
Name | Appointed On | Resigned On | Role | Address | Company Identification | Country of Residence | Nationality | Date of Birth | Occupation | Number |
---|---|---|---|---|---|---|---|---|---|---|
CHIA, Dr Poh Hui | Director | Tower 1 Harbourfront Avenue, 098632 #16-06 Keppel Bay Singapore | Singapore | Singaporean | Associate Director | 318088170001 | ||||
DE GODOI MATTOS FERREIRA, Ricardo, Dr | Director | Wootton Road OX13 6BH Abingdon 4 & 5 Dunmore Court Oxfordshire England | Brazil | Brazilian | Biologist, Researcher | 315837090001 | ||||
JACKSON, David Clifford | Director | Wootton Road OX13 6BH Abingdon 4 & 5 Dunmore Court Oxfordshire England | England | British | Company Director | 146695910001 | ||||
MOORE-THORNICROFT, Storme Jo-Anne | Director | Wootton Road OX13 6BH Abingdon 4 & 5 Dunmore Court Oxfordshire England | United Kingdom | British | Director | 72581670003 | ||||
PAGANI, Sergio | Director | Wootton Road OX13 6BH Abingdon 4 & 5 Dunmore Court Oxfordshire England | United Kingdom | Luxembourger | Director | 249181030003 | ||||
RADEMACHER, Thomas William, Professor | Director | Wootton Road OX13 6BH Abingdon 4 & 5 Dunmore Court Oxfordshire England | England | American | Director | 72581680001 | ||||
SENG CHIN, Finian Tan, Dr | Director | Harbourfront Avenue 098632 16-06 Keppel Bay Tower 1 Singapore | Singapore | Singaporean | Entrepreneur | 262326870001 | ||||
TUFARO, Frank | Director | Sitio Avellana CA92009 Carlsbad 3246 United States | United States | American | Company Director | 299191460001 | ||||
BRADMAN, Godfrey Michael | Director | Berkeley Street W1J 8DJ London 1 England | England | British | Director | 2068500003 | ||||
DONG, Yixiang | Director | Wootton Road OX13 6BH Abingdon 4 & 5 Dunmore Court Oxfordshire England | England | Chinese | Accountant And Scientist | 238610240001 | ||||
JACKSON, David Clifford | Director | Burges Grove SW13 8BG London 7 England | England | British | Director | 146695910001 | ||||
KING, David Anthony, Sir | Director | Glisson Road CB1 2HD Cambridge 20 United Kingdom | England | British | Director | 90952010001 | ||||
LIM, Xinhong, Dr | Director | 3rd St San Francisco 95 California, 94103 United States | United States | Singaporean | Director | 277122270001 | ||||
OAKES, Herbert | Director | Grosvenor Street W1K 4QW London 26 England | England | American | Director | 195778730001 | ||||
PHILIP, Mohan, Dr | Director | Corleone Drive Sparks 1810 Nv United States | United States | American | Company Director | 229757670002 | ||||
RAKE, Michael Derek Vaughn, Sir | Director | Wootton Road OX13 6BH Abingdon 4 & 5 Dunmore Court Oxfordshire England | England | British | Company Director | 304063480001 | ||||
SEDGWICK, Anthony David, Professor | Director | Wootton Road OX13 6BH Abingdon 4 & 5 Dunmore Court Oxfordshire England | England | English | Director | 151673490001 |
Who are the persons with significant control of GYLDEN PHARMA LIMITED?
Name | Notified On | Address | Ceased |
---|---|---|---|
Professor Thomas William Rademacher | Apr 06, 2016 | Wootton Road OX13 6BH Abingdon 4 & 5 Dunmore Court Oxfordshire England | No |
Nationality: American Country of Residence: England | |||
Natures of Control
|
Data Source
- UK Companies House
The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings. - license: CC0